Finance

Beta
Lists
1786:TPE
SciVision Biotech Inc
NT$55.00
+0.18%
(+0.100) 1D
Jun 5, 10:06:30 AM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1786...
Open
NT$55.70
High
NT$56.00
Low
NT$54.70
Mkt. cap
4.12B
Avg. vol.
468.78K
Volume
102.53K
Dividend
3.47%
Quarterly dividend
NT$0.48
Ex-dividend date
Jul 26, 2023
P/E ratio
34.05
52-wk high
NT$124.00
52-wk low
NT$51.30
EPS
NT$1.62
Shares outstanding
53.10M
No. of employees
64
Open
NT$55.70
High
NT$56.00
Low
NT$54.70
Mkt. cap
4.12B
Avg. vol.
468.78K
Volume
102.53K
Dividend
3.47%
Quarterly dividend
NT$0.48
Ex-dividend date
Jul 26, 2023
P/E ratio
34.05
52-wk high
NT$124.00
52-wk low
NT$51.30
EPS
NT$1.62
Shares outstanding
53.10M
No. of employees
64
News stories
From sources across the web
About SciVision Biotech Inc
CEO-
Employees64
Founded1990
Headquarters-
SectorMedical device
Websitescivision.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
209.49M
221.41M
251.39M
205.32M
Cost of goods sold
56.70M
67.33M
62.04M
60.12M
Cost of revenue
56.70M
67.33M
62.04M
60.12M
Research and development expenses
20.67M
21.26M
32.38M
22.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.17M
86.38M
107.04M
100.96M
Operating expense
119.84M
107.65M
139.42M
123.90M
Total operating expenses
176.54M
174.97M
201.46M
184.02M
Operating income
32.95M
46.44M
49.93M
21.30M
Other non operating income
-5.43M
2.10M
2.19M
11.01M
EBT including unusual items
-32.77M
71.72M
72.40M
35.68M
EBT excluding unusual items
-32.77M
71.72M
74.54M
35.68M
Income tax expense
-16.74M
13.39M
9.21M
13.73M
Effective tax rate
51.09%
18.68%
12.72%
38.47%
Other operating expenses
-
-
-
-
Net income
-16.03M
58.32M
63.18M
21.96M
Net profit margin
-7.65%
26.34%
25.13%
10.69%
Earnings per share
-
-
-
-
Interest and investment income
5.73M
4.76M
8.75M
6.50M
Interest expense
-1.21M
-2.43M
-3.18M
-3.12M
Net interest expenses
4.52M
2.34M
5.57M
3.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
50.10M
63.95M
68.84M
43.79M
Gain or loss from assets sale
-
-
10.00K
16.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer